JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M304370200 on July 7, 2003

J. Biol. Chem., Vol. 278, Issue 38, 36099-36106, September 19, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/38/36099    most recent
M304370200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nyunoya, T.
Right arrow Articles by Hunninghake, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nyunoya, T.
Right arrow Articles by Hunninghake, G. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Hyperoxia Induces Macrophage Cell Cycle Arrest by Adhesion-dependent Induction of p21Cip1 and Activation of the Retinoblastoma Protein*

Toru Nyunoya {ddagger}, Linda S. Powers, Timur O. Yarovinsky, Noah S. Butler, Martha M. Monick and Gary W. Hunninghake

From the Division of Pulmonary, Critical Care, and Occupational Medicine, University of Iowa Roy J. and Lucille A. Carver College of Medicine and Veterans Administration Medical Center, Iowa City, Iowa 52242

Received for publication, April 26, 2003 , and in revised form, June 23, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Hyperoxia induces growth arrest, apoptosis, necrosis, and morphological changes (spreading and adhesion) in various types of cells. The mechanism of hyperoxia-induced cell growth arrest has not been well elucidated, especially in macrophages. One possible mechanism is a role of cell adhesion in hyperoxia-induced cell cycle arrest. To evaluate this finding, macrophages were cultured in normoxia (21% O2) or hyperoxia (95% O2) in adhesion or low adhesion conditions. Incubation of macrophages in hyperoxia induced cell cycle arrest. The hyperoxia-induced cell cycle arrest was prevented by low adhesion conditions. To evaluate pathways potentially involved in hyperoxia-induced growth arrest, we measured extracellular regulated kinase and retinoblastoma protein activation and p21Cip1 and p53 accumulation. Hyperoxia strongly induced activation of extracellular regulated kinase and retinoblastoma protein as well as up-regulation of p21Cip1. These effects of hyperoxia were attenuated under low adhesion conditions, suggesting a role for integrin-dependent signaling. The induction of p21Cip1 and activation of retinoblastoma protein occurred via a p53-independent mechanism. These results suggest that adhesion-dependent pathways are required for hyperoxia-induced cell cycle arrest in macrophages.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Hyperoxia causes damage to DNA, lipids, and proteins leading to cell cycle arrest and subsequent cell death (17). Hyperoxia-induced growth arrest has been evaluated in epithelial cells (26) and endothelial cells (8, 9); however, little is known regarding the effects of hyperoxia on macrophages. What has been described is the effect of hyperoxia on stimulus-induced cytokine production (10) and hyperoxia-induced cell spreading associated with the effects on actin (13). Animal models have shown that hyperoxia induces recruitment of macrophages to the lungs (11) but decreases antibacterial function (12, 13) and cell migration (14). In this study, we evaluated the effect of hyperoxia on macrophage proliferation and cell cycle regulation.

In contrast to macrophages, more is known regarding the effects of hyperoxia on epithelial cells. In epithelial cells, hyperoxia inhibits proliferation through activation of cell cycle checkpoints until DNA damage is repaired. This phenomenon is critical for maintaining genomic integrity (3, 5, 15). Various proteins are known to be key regulators of the cell cycle, including cyclins, cyclin-dependent kinases (CDK),1 and CDK inhibitors (CKI). Cyclin-CDK complexes positively regulate cell cycle progression and are negatively controlled by CKIs (16, 17). CKIs are divided into two classes on the basis of their homology, the Kip/Cip family (p21Cip1, p27Kip1, and p57Kip2) and the INK4 family (p16INK4a, p15INK4b, p18INK4C, and p19INK4d). The Kip/Cip family inhibits a broad range of CDKs (17, 18). Increases in p21Cip1 (p21) have been shown to play a central role in hyperoxia-induced growth arrest (1921). p21 has also been shown to play a crucial role in cell cycle control in response to the other stimuli such as glucocorticoids (22) and cigarette smoke (23). In lung epithelial cells, a marked increase in p21 has been observed after oxygen exposure (15). A study by Corroyer et al. (15) found that one target of p21 action was the cyclin E-CDK2 complex that facilitates cell cycle progression to the S phase (15). Induction of p21 can occur via p53-dependent (24, 25) and p53-independent mechanisms (2629). Induction of p21 independent of p53 has been reported in hyperoxia conditions (30).

Hyperoxia induces morphological changes including cell spreading (13). Previously, we reported that cell adhesion (integrin signaling) was required for lipopolysaccharide-induced activation of the mitogen-activated kinase (MAPK), extracellular regulated kinase (ERK), and optimal tumor necrosis factor-{alpha} production (31). In this study, we evaluated the role of adhesion (tissue culture plates and extracellular matrix-coated plates with collagen type I, collagen type IV, or fibronectin) on hyperoxia-induced growth arrest in macrophages. The studies show that growth arrest was accompanied by increased amounts of macrophage spreading, ERK activation, p21 induction, and retinoblastoma protein (Rb) activation. These effects of hyperoxia occurred via a p53-independent mechanism and were reversed by blocking cell adhesion. These data suggest that hyperoxia-induced growth arrest requires an integrin-dependent signal.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Reagents and Antibodies—Chemicals were obtained from Sigma. Protease inhibitors were obtained from Roche Applied Science. Nitrocellulose filters and ECL Plus were obtained from Amersham Biosciences. Antibodies were obtained from various sources. Anti-p21 was from Santa Cruz Biotechnology (Santa Cruz, CA), and phosphorylation-specific antibodies for ERK and Rb were from Cell Signaling (Beverly, MA). Developing antibodies (horseradish peroxidase-conjugated anti-rabbit or anti-mouse Ig) were obtained from Santa Cruz Biotechnology. Tissue culture plates and special adherence-free plates (Teflon-coated Ultra Low Attachment) were obtained from Corning (Corning, NY). Extracellular matrix-coated plates with collagen type I, collagen type IV, or fibronectin were obtained from BD Biosciences (Bedford, MA).

Cell Culture and Cell Proliferation—RAW264.7 cells (TIB-71, American Type Culture Collection) were maintained at 37 °C and in Dulbecco's modified Eagle's medium (high glucose) with 10% fetal bovine serum and gentamicin (40 µg/ml). Cells were subcultured every 2–3 days. Experiments were performed in six-well (35 mm) Costar tissue culture plates (low-adherence or standard) or extracellular matrix-coated (collagen type I, collagen type IV, or fibronectin) plates (35 mm) under normoxia (FiO2 = 21%) or in hyperoxia (FiO2 = 95%) at the starting cell density of 0.5 x 106/ml. The cells were removed by scraping, suspended in the original medium, and centrifuged at 300 x g. The cells were resuspended in 3 ml of 1x Dulbecco's phosphate-buffered saline and counted with an electric particle counter (Coulter Electronics, Hialeah, FL).

Isolation of Whole Cell Extracts—Whole cell protein was obtained by lysing the cells on ice for 20 min in 500 µl of lysis buffer (0.05 M Tris, pH 7.4, 0.15 M NaCl, 1% Nonidet P-40, 0.5 M phenylmethylsulfonyl fluoride, 50 µg/ml aprotinin, 10 µg/ml leupeptin, 50 µg/ml pepstatin, 0.4 mM sodium orthovanadate, 10 mM sodium fluoride, and 10 mM sodium pyrophosphate; all from Roche Applied Science). The lysates were then sonicated for 20 s, incubated on ice for 30 min, and centrifuged at 15,000 x g for 10 min at 4 °C. Protein was quantified using a protein measurement kit (protein assay kit 500-0006, Bio-Rad). Cell lysates were stored at -70 °C until use.

Western Blot Analysis—Western blot analysis for the presence of particular proteins or for phosphorylated forms of proteins was performed on whole cell proteins. Protein (30–80 µg) was mixed 1:1 with 2x sample buffer (20% glycerol, 4% SDS, 10% mercaptoethanol, 0.05% bromphenol blue, and 1.25 M Tris, pH 6.8; all from Sigma), heated to 95 °C for 5 min, and fractionated on a 10 or 12.5% SDS-polyacrylamide gel run at 100 V for 90 min. Cell proteins were transferred to nitrocellulose filters (ECL) by semidry transfer (Bio-Rad) at 20 V for 45 min. Equal loading of the protein groups on the blots was evaluated by using Ponceau S, a staining solution designed for staining proteins on nitrocellulose membranes (Sigma). The nitrocellulose filter was blocked with 5% milk in Tris-buffered saline with 0.1% Tween 20 for 1 h, washed, and then incubated with the primary antibody overnight. The blots were washed four times with Tris-buffered saline with Tween 20 and incubated for 1 h with horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG antibody. Immunoreactive bands were developed using a chemiluminescent substrate (ECL Plus or SuperSignal West Femto). An autoradiograph was obtained with exposure times of 10 s to 2 min.

Flow Cytometry—RAW264.7 cells were cultured in conditions of normoxia (21% O2) or hyperoxia (95% O2 and 5% CO2) on adhesion plates or low adhesion plates for 24 h. The cells were washed twice in phosphate-buffered saline and fixed in cold 70% ethanol overnight. After two washes in phosphate-buffered saline, the cells were treated with 0.25 mg/ml RNase A (Roche Applied Science) and stained with 50 µg/ml propidium iodide at 4 °C for 30 min in the dark and analyzed for DNA content. A total of 10,000 cells that satisfied a gate on forward and side scatter to eliminate aggregates and debris were evaluated with a FACScan flow cytometer (BD Biosciences). Data analysis was performed with ModFit LT (Verity Software House Inc, Topsham, ME).

Real-time RT-PCR—Total RNA was isolated using the Absolutely RNA RT-PCR miniprep kit (Stratagene, La Jolla, CA) following the manufacturer's instructions. RNA was quantitated using RiboGreen Kit (Molecular Probes, Eugene, OR). 1 µg of total RNA was reverse-transcribed to cDNA using RETROscript RT-PCR kit (Ambion, Austin, TX). In a 0.2-ml PCR tube (Bio-Rad), 2 µl of cDNA (10% cDNA synthesis reaction volume) was added to 48 µl of PCR reaction mixture containing 160 µM each dNTP (Invitrogen), 3.0 mM MgCl2 (Invitrogen), 1:10,000 SYBR Green I DNA dye (Molecular Probes), 0.2 µM of each sense and antisense primers (IDT, Coralville, IA), and 2.5 units of Platinum TaqDNA polymerase (Invitrogen). Amplification was then performed in an iCycler iQ Fluorescence Thermocyler (Bio-Rad) as follows: 5 min at 95 °C followed by 45 cycles of 20 s at 95 °C, 20 s at 60 °C, and 20 s at 72 °C. Fluorescence data were captured during the 72 °C dwell time. Specificity of the amplification was confirmed using melting curve analysis. Data were collected and recorded by iCycler iQ software (Bio-Rad) and expressed as a function of threshold cycle (Ct), the cycle at which the fluorescence intensity in a given reaction tube rises above background (calculated as 10 times the mean ± S.D. of fluorescence in all of the wells over the base-line cycles). Specific primer sets used are as follows (5' to 3'): p21 sense, TCCACAGCGATATCCAGACA; p21 antisense, CAGGGCAGAGGAAGTACTGG; HPRT sense, CCTCATGGACTGATTATGGAC; and HPRT antisense, CAGATTCAACTTGCGCTCATC. Primers were selected based on nucleotide sequences downloaded from the National Center for Biotechnology Information data bank and designed with software by Steve Rozen and Helen J. Skaletsky (1998 Primer3, code available at www-genome.wi.mit.edu/genome_software/other/primer3.html).

Quantitative Gene Expression—Quantitative p21 mRNA expression was calculated as follows. For each sample assayed, the Ct for reactions amplifying p21 and the HPRT housekeeping gene were determined. The p21 Ct for each sample was corrected by subtracting the Ct for HPRT ({Delta}Ct). Finally, p21 mRNA abundance, relative to HPRT mRNA abundance, was calculated by the formula 2-({Delta}Ct). Validity of this approach was confirmed by using serial 10-fold dilutions of template for p21 and HPRT. Using the 10-fold dilutions, the amplification efficiencies for p21 and HPRT were found to be identical.

Statistical Analysis—The results were expressed as the mean ± S.E. The number of cells in each condition at various time points in adherence or non-adherence conditions was compared using a unpaired Student's t test.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Hyperoxia Induces Macrophage Growth Arrest—To investigate the effects of hyperoxia on RAW264.7 cells (macrophages), we performed the following experiments. Macrophages were cultured in standard tissue culture plates and extracellular matrix-coated (collagen type I, collagen type IV, or fibronectin) plates under conditions of normoxia (21% O2) or hyperoxia (95% O2) at the starting cell density of 0.5 x 106/ml. Cell counts were measured at various time points as described under "Experimental Procedures." As shown in Fig. 1A, hyperoxia-induced cell growth arrest was significant at 24 and 48 h (p < 0.05) in both standard tissue culture plates and extracellular matrix-coated plates with collagen type I, collagen type IV, or fibronectin. Fig. 1B shows morphological changes demonstrating a greater degree of cell spreading in the hyperoxia group on all of the substrates at 48 h. These studies show that hyperoxia decreases cell proliferation and induces morphological changes in macrophages.



View larger version (45K):
[in this window]
[in a new window]
 
FIG. 1.
Hyperoxia induces macrophage growth arrest. A, RAW264.7 cells were cultured on regular tissue culture plates or extracellular matrix-coated (collagen type I, collagen type IV, or fibronectin) under normoxia (21% O2) or hyperoxia (95% O2 and 5% CO2) at the starting cell density 0.5 x 106/ml. The cell counts were measured at various time points (2, 24, and 48 h). Data are expressed as mean ± S.E. for three independent experiments (*, p < 0.05). B, RAW264.7 cells were treated as in A, and the digital photographs were obtained at 48 h. The photographs represent one of three identical experiments.

 

Hyperoxia-induced Growth Arrest Requires Cell Adhesion— Because hyperoxia induced marked morphological changes associated with cell spreading (13), we postulated that an increase in cell adhesion by hyperoxia might contribute to cell growth arrest. To evaluate this possibility, macrophages were cultured in normoxia (21% O2) or hyperoxia (95% O2) in standard tissue culture plates or low adherence plates. The number of cells was measured at 2, 24, and 48 h. As shown in Fig. 2A, low adhesion conditions blocked hyperoxia-induced cell growth arrest. These results suggest that hyperoxia-induced cell growth arrest is dependent on cell adhesion.



View larger version (17K):
[in this window]
[in a new window]
 
FIG. 2.
Hyperoxia-induced growth arrest requires cell adhesion. A, RAW264.7 cells were cultured in conditions of normoxia (21% O2) or hyperoxia (95% O2 and 5% CO2) on adhesion plates or low adhesion plates at the starting cell density 0.5 x 106/ml. The cell counts were measured at various time points (2, 24, and 48 h). Data are expressed as mean ± S.E. for three independent experiments (*, p< 0.05, normoxia/adhesion compared with hyperoxia/adhesion). B, RAW264.7 cells were treated as in A, and flow cytometry with DNA assay was performed as described under "Experimental Procedures." Synthetic phase percent was measured at 24 h. Data are expressed as mean ± S.E. for three independent experiments (*, p < 0.05, normoxia/adhesion compared with hyperoxia/adhesion).

 

Hyperoxia Induces Growth Arrest at the G0/G1 Phase of the Cell Cycle—Hyperoxia has been reported to induce cell cycle arrest and apoptosis or necrosis (17, 32). To determine whether hyperoxia induced adhesion-dependent cell cycle arrest, we performed flow cytometry with DNA staining by propidium iodide. Cell cycle was analyzed at 24 h with four conditions, adhesion conditions with normoxia (21% O2) or hyperoxia (95% O2) and low adhesion conditions with normoxia or hyperoxia. Cell cycle analysis showed that hyperoxia induced a significant decrease in the S phase at 24 h (Fig. 2B) associated with cell cycle arrest at the G0/G1 phase (data not shown). There was no evidence for apoptosis in hyperoxia conditions up to 48 h (data not shown). Taken together, the data show that hyperoxia induces an adherence-dependent G1 phase cell growth arrest with limited cell death.

Hyperoxia Induces ERK Activity That Is Dependent on Adhesion—Hyperoxia has been shown to induce the activation of ERK MAPK (32). Previously, we showed that cell adhesion was necessary to induce optimal activation of ERK in macrophages stimulated by lipopolysaccharide (31). Based on these observations, we hypothesized that hyperoxia-induced activation of ERK might be attenuated by low adhesion. To evaluate this hypothesis, macrophages were cultured in adhesion or low adhesion conditions with normoxia (21% O2) or hyperoxia (95% O2). Western blot analysis was performed for phosphorylation of ERK. Hyperoxia induced a sustained markedly increased phosphorylation of ERK in cells cultured in adhesion conditions (Fig. 3A). Notably, low adhesion reversed the hyperoxia-induced ERK activity as shown in Fig. 3B. Pharmacological inhibition of ERK led to hyperoxia-induced cell death (data not shown), not increased cell proliferation. This finding suggests that the cell cycle arrest is not the result of the hyperoxia induced ERK activity and that other hyperoxia-inducible factors may play a role in cell cycle arrest. As a composite, these data suggest that hyperoxia-induced ERK activation is adhesion-dependent and may play a role in cell survival in hyperoxia conditions but is not linked to the cell cycle arrest demonstrated in Figs. 1 and 2.



View larger version (19K):
[in this window]
[in a new window]
 
FIG. 3.
Hyperoxia induces ERK activity that is dependent on adhesion. RAW264.7 cells were cultured in conditions of normoxia (21% O2) or hyperoxia (95% O2 and 5% CO2) on adhesion plates or low adhesion plates for 48 h. Western blot analysis was performed for phosphorylation of ERK. Densitometry of phosphorylated ERK is shown as fold increase (mean optical density units in experimental sample/mean optical density units in normoxia/adhesion sample). Western blotting data are representative of three experiments.

 

Hyperoxia Induces Cell Cycle Arrest via an Adhesion-dependent Induction of p21—Hyperoxia has been shown to induce cell growth arrest by CKIs (36, 30), and p21 is a major CKI linked to cell growth arrest at the G1 phase (33, 34). For these reasons, we analyzed the effect of hyperoxia on p21 accumulation. Macrophages were cultured in adherence or non-adherence conditions with normoxia (21% O2) or hyperoxia (95% O2). Western blot analysis and mRNA quantification were performed for p21. As shown in Fig. 4, A and B, hyperoxia induced accumulation of both p21 protein and mRNA and this was blocked by low adhesion. We also performed Western blot analysis for p53, which can under some conditions be upstream of p21. The accumulation of p21 was independent of p53, because hyperoxia decreased amounts of p53 (Fig. 4C). These results demonstrate that hyperoxia induces an adhesion-dependent induction of p21, which is independent of p53.



View larger version (24K):
[in this window]
[in a new window]
 
FIG. 4.
Hyperoxia induces p21 accumulation. A, RAW264.7 cells were cultured in conditions of normoxia (21% O2) or hyperoxia (95% O2 and 5% CO2) on adhesion plates or low adhesion plates for 48 h. Western blot analysis was performed for p21 in the whole cell lysates. B, RAW264.7 cells were treated as in A, and total RNA was isolated at 24 h. p21 mRNA quantitative RT-PCR was performed as described under "Experimental Procedures." Data are expressed as mean ± S.E. for four independent experiments (**, p < 0.01, normoxia/adhesion compared with hyperoxia/adhesion). C, RAW264.7 cells were treated as in A, and Western blot analysis was performed for p53 in the whole cell lysates. Densitometries of p21 and p53 are shown as fold increase (mean optical density units in experimental sample/mean optical density units in normoxia/adhesion sample). Western blotting data are representative of three experiments.

 

Hyperoxia Increases Rb Hypophosphorylation in an Adhesiondependent Manner—Phosphorylation of Rb decreases its ability to cause cell cycle arrest. p21 induces cell cycle arrest, in part, by decreasing phosphorylation of Rb (17, 18). For this reason, we postulated that hyperoxia-induced p21 accumulation would lead to hypophosphorylation of Rb. Macrophages were cultured in adherence or non-adherence conditions with normoxia (21% O2) or hyperoxia (95% O2). Western blot analysis was performed to determine the phosphorylation state of Rb. As shown in Fig. 5, hyperoxia decreased phosphorylation of Rb. The increase in hypophosphorylated Rb did not occur in low adhesion conditions. These results are consistent with the p21 data and cell cycle analyses shown above. As a composite, the data suggest that hyperoxia requires adhesion-dependent signals to induce p21, activate Rb, and cause cell cycle arrest.



View larger version (29K):
[in this window]
[in a new window]
 
FIG. 5.
Hyperoxia decreases Rb phosphorylation in an adhesion-dependent manner. RAW264.7 cells were cultured in conditions of normoxia (21% O2) or hyperoxia (95% O2 and 5% CO2) on adhesion plates or low adhesion plates for 24 h. Western blot analysis was performed for hyperphosphorylation of Rb (inactive state). Densitometry of hyperphosphorylated Rb is shown as fold increase (mean optical density units in experimental sample/mean optical density units in normoxia/adhesion sample). Western blotting data are representative of three experiments.

 


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
This study demonstrates that in macrophages, hyperoxia inhibits cell proliferation and induces morphological changes such as cell spreading. Hyperoxia-induced growth arrest occurred in both standard tissue culture plates and extracellular matrix-coated plates with collagen type I, collagen type IV, or fibronectin. The hyperoxia-induced growth arrest was accompanied by p21 induction and Rb activation. All of these observations were dependent on cell adhesion as cells cultured in low adhesion conditions continued to proliferate and did not increase p21 or Rb activity. The effects were not dependent on p53 activity. Interestingly, hyperoxia induced ERK activity and this was blocked by low adhesion conditions. Inhibition of ERK activity, however, did not reverse the growth arrest but facilitated cell death, suggesting that hyperoxia-induced ERK was important for cell survival under hyperoxia conditions. As a composite, these data show that in macrophages, hyperoxia/adherence induces cell survival in part via an effect on ERK MAPK and cell cycle arrest via an effect of p21 induction and Rb activation.

A number of studies have evaluated the effects of hyperoxia on cell cycle in non-macrophage cell lines. It has been reported that hyperoxia inhibits cell proliferation and induces cell death in A549 epithelial cells (2, 6), MLE15 murine type II epithelial cells (3), HCT116 colon carcinoma cells (4), Mv1Lu pulmonary adenocarcinoma cells (5, 6) and HeLa cells (7). However, few studies have examined the effect of hyperoxia on cell cycle and survival in macrophages. Human alveolar macrophages proliferate at very low levels in normal lungs. A study of 14 normal subjects showed no significant change in the number of alveolar macrophages in response to hyperoxia (>95% O2) for 17 h (35). In contrast, Nerurkar et al. (36) investigated the effect of hyperoxia on the cell cycle in rabbit alveolar macrophages. Alveolar macrophages exposed to hyperoxia for 18 h increased incorporation of [3H]thymidine and proliferation (36). Thus, the effects of hyperoxia on macrophages in terms of cell cycle and survival remain poorly defined. RAW264.7 cells were chosen for this study because they are a well developed macrophage cell line that proliferates rapidly and has been used as a model for cell cycle analyses. We found that hyperoxia induces G1 phase cell cycle arrest and marked morphological changes such as cell spreading in macrophages. These changes were dependent on signals downstream of cell adhesion. Our data suggest a novel mechanism of cell growth control, i.e. adhesiondependent hyperoxia-induced cell cycle arrest. The growth arrest did not result in cell death during the time frame studied, potentially because of the hyperoxia-induced ERK activation.

Previously, we found that ERK (p42/p44) activity was regulated by cell adhesion in macrophages (31). Moreover, it has been reported that ERK activity can be induced by hyperoxic exposure and leads to hyperoxia-induced apoptosis (32). Our studies showed that hyperoxia-induced ERK activity was mediated by cell adhesion and appeared to maintain cell viability. We observed minimal cell death under conditions of hyperoxia unless ERK activity was inhibited. Therefore, we speculate that activation of ERK by hyperoxia in macrophages functions as a survival signal rather than a pro-apoptotic signal as suggested by other studies (3739).

A report by Corroyer et al. (15) describes a marked increase in p21 in lung epithelial cells of rats under hyperoxia. p21 has been shown to play a dual role in cell cycle progression. It acts as an inhibitor of the cyclin E-CDK2 complex, which facilitates cell cycle progression to S phase (15), and as an assembly activator of cyclin D-CDK4 complexes (40, 41). Activation of p21 also induces cell cycle arrest by preventing DNA synthesis. p21 binds to proliferating cell nuclear antigen, a co-activator of DNA polymerases{delta} and {epsilon}(42), and modulates the primer template recognition complex, which inhibits DNA replication (43). p21 has been suggested to play a role not only in the functions of cell cycle control but also in enhancing cell survival and differentiation. Several studies have shown increased susceptibility to p53-mediated apoptosis in p21-deficient cells (44, 45). Moreover, ectopic p21 expression in p21-deficient mouse embryonal fibroblasts protected against p53-induced apoptosis (45). Asada et al. (46) have reported that ectopic expression of p21 in U937 cells resulted in monocytic differentiation and resistance to various apoptotic stimuli (46).

p21 can be induced by p53-dependent (24, 25) and/or p53-independent mechanisms (2629). We found that hyperoxia induced p21 accumulation by a p53-independent mechanism. Although p53 has been suggested to play a critical role in p21 induction following DNA damage (47), several studies have shown p53-independent pathways mediated by various transcription factors including Sp1 (26), activator protein 2 (27), STAT1 (28), and CCAAT/enhancer-binding protein (29). O'Reilly et al. (30) have shown that in vivo exposure of lungs to hyperoxia increases p53-independent expression of p21 in p53-deficent mice but to a lesser extent than observed for p53+/+ mice (30). In A549 adenocarcinoma cells, Rancourt et al. (6) demonstrated p53-dependent induction of p21 by hyperoxia. These data suggest that hyperoxia-induced p21 accumulation may occur via both pathways. It is possible that cell adhesion may determine whether p21 is induced by p53-dependent or p53-independent mechanisms. In this regard, hyperoxia has been shown to induce p53 in proliferating but not in confluent Mv1Lu adenocarcinoma cells (5). One possible upstream inducer of p53-independent p21 is the ERK MAPK. Several studies have demonstrated that highly activated Raf-1 elicited p53-independent induction of p21 and cell cycle arrest in murine NIH 3T3 cells (48, 49). Sustained activation of MAPK through activated Raf-1 has been also shown to result in induction of p21 transcription and cell cycle arrest in NIH 3T3 cells (50). This finding suggests that the hyperoxia/adhesion-dependent activation of the ERK MAPK pathway may contribute to the p53-independent induction of p21.

The eukaryotic cell cycle is traditionally divided into four phases, a gap phase (G0/G1), a synthesis phase (S), a second gap phase (G2), and mitosis (M). The retinoblastoma tumor suppressor protein (Rb) is a key player in cell cycle arrest at the G1/S phase (18, 51, 52). The activity of Rb is down-regulated by phosphorylation (18). Activation or hypophosphorylation of Rb can be induced through p21-dependent (53) or p21-independent pathways (54). Cicchillitti et al. (54) describe oxidative-induced hypophosphorylation of Rb not dependent on p21 but on the activity of protein phosphatase 2A in human umbilical vein endothelial cells (54). In contrast, the G1 phase arrest by flavone, anti-proliferative agent derived from plants, is because of p53-independent transcriptional induction of the p21 gene and the subsequent hypophosphorylation of Rb in A549 cells (53). We found that activation of Rb was induced with p21 accumulation in an adhesion-dependent manner under conditions of hyperoxia.

In conclusion, this study demonstrates that hyperoxia induces cell cycle arrest that is dependent on cell adhesion. Hyperoxia induces both p21 accumulation and Rb activation, also in an adhesion-dependent manner. Hyperoxia also induces ERK activation via an adhesion-dependent mechanism that was linked to cell survival under hyperoxia conditions. The novel observations of this study, adhesion-dependent induction of p21 protein, activation of Rb, and cell cycle arrest suggests a previously unknown role for integrin signaling in macrophage responses to hyperoxia.


    FOOTNOTES
 
* This work was supported by a Veterans Administration merit review grant, National Institutes of Health Grants HL-60316 and ES-09607, Environmental Protection Agency Grant R82671 [GenBank] 1 (to G. W. H.), and National Center for Research Resources, National Institutes of Health Grant RR00059 from the General Clinical Research Centers Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

{ddagger} To whom correspondence should be addressed: Division of Pulmonary, Critical Care, and Occupational Medicine, 100 Ekstein Medical Research Bldg., Iowa City, IA 52242. Tel.: 319-335-7590; Fax: 319-335-6530; E-mail:toru-nyunoya{at}uiowa.edu.

1 The abbreviations used are: CDK, cyclin-dependent kinases; CKI, CDK inhibitors; MAPK, mitogen-activated protein kinase; ERK, extracellular signal-regulated kinase; Rb, retinoblastoma; RT, reverse transcription; Ct, threshold cycle; STAT, signal transducers and activators of transcription; INK4, inhibitors of cyclin-dependent kinase 4; HPRT, hypoxantine-guanine phosphoribosyltransferase. Back



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Cacciuttolo, M. A., Trinh, L., Lumpkin, J. A., and Rao, G. (1993) Free Radical Biol. Med. 14, 267-276[CrossRef][Medline] [Order article via Infotrieve]
  2. Li, Y., Zhang, W., Mantell, L. L., Kazzaz, J. A., Fein, A. M., and Horowitz, S. (1997) J. Biol. Chem. 272, 20646-20649[Abstract/Free Full Text]
  3. O'Reilly, M. A., Staversky, R. J., Finkelstein, J. N., and Keng, P. C. (2003) Am. J. Physiol. 284, L368-L375
  4. Helt, C. E., Rancourt, R. C., Staversky, R. J., and O'Reilly, M. A. (2001) Toxicol. Sci. 63, 214-222[Abstract/Free Full Text]
  5. Rancourt, R. C., Hayes, D. D., Chess, P. R., Keng, P. C., and O'Reilly, M. A. (2002) J. Cell. Physiol. 193, 26-36[CrossRef][Medline] [Order article via Infotrieve]
  6. Rancourt, R. C., Keng, P. C., Helt, C. E., and O'Reilly, M. A. (2001) Am. J. Physiol. 280, L617-L626
  7. Schoonen, W. G., Wanamarta, A. H., van der Klei-van Moorsel, J. M., Jakobs, C., and Joenje, H. (1990) Mutat. Res. 237, 173-181[CrossRef][Medline] [Order article via Infotrieve]
  8. Martin, W. J., II, and Kachel, D. L. (1989) J. Lab. Clin. Med. 113, 413-421[Medline] [Order article via Infotrieve]
  9. Junod, A. F., Petersen, H., and Jornot, L. (1987) J. Appl. Physiol. 62, 10-14[Abstract/Free Full Text]
  10. Desmarquest, P., Chadelat, K., Corroyer, S., Cazals, V., and Clement, A. (1998) Respir. Med. 92, 951-960[CrossRef][Medline] [Order article via Infotrieve]
  11. Coalson, J. J., King, R. J., Winter, V. T., Prihoda, T. J., Anzueto, A. R., Peters, J. I., and Johanson, W. G., Jr. (1989) J. Appl. Physiol. 67, 346-356[Abstract/Free Full Text]
  12. Suttorp, N., and Simon, L. M. (1983) Am. Rev. Respir. Dis. 128, 486-490[Medline] [Order article via Infotrieve]
  13. O'Reilly, P. J., Hickman-Davis, J. M., Davis, I. C., and Matalon, S. (2003) Am. J. Respir. Cell Mol. Biol. 28, 443-450[Abstract/Free Full Text]
  14. Bowles, A. L., Dauber, J. H., and Daniele, R. P. (1979) Am. Rev. Respir. Dis. 120, 541-545[Medline] [Order article via Infotrieve]
  15. Corroyer, S., Maitre, B., Cazals, V., and Clement, A. (1996) J. Biol. Chem. 271, 25117-25125[Abstract/Free Full Text]
  16. Pavletich, N. P. (1999) J. Mol. Biol. 287, 821-828[CrossRef][Medline] [Order article via Infotrieve]
  17. Morgan, D. O. (1997) Annu. Rev. Cell Dev. Biol. 13, 261-291[CrossRef][Medline] [Order article via Infotrieve]
  18. Sherr, C. J., and Roberts, J. M. (1999) Genes Dev. 13, 1501-1512[Free Full Text]
  19. McGrath, S. A. (1998) Am. J. Respir. Cell Mol. Biol. 18, 179-187[Abstract/Free Full Text]
  20. Shenberger, J. S., and Dixon, P. S. (1999) Am. J. Respir. Cell Mol. Biol. 21, 395-402[Abstract/Free Full Text]
  21. O'Reilly, M. A., Staversky, R. J., Watkins, R. H., and Maniscalco, W. M. (1998) Am. J. Respir. Cell Mol. Biol. 19, 777-785[Abstract/Free Full Text]
  22. Corroyer, S., Nabeyrat, E., and Clement, A. (1997) Endocrinology 138, 3677-3685[Abstract/Free Full Text]
  23. Marwick, J. A., Kirkham, P., Gilmour, P. S., Donaldson, K., Macnee, W., and Rahman, I. (2002) Ann. N. Y. Acad. Sci. 973, 278-283[Abstract/Free Full Text]
  24. Dulic, V., Kaufmann, W. K., Wilson, S. J., Tlsty, T. D., Lees, E., Harper, J. W., Elledge, S. J., and Reed, S. I. (1994) Cell 76, 1013-1023[CrossRef][Medline] [Order article via Infotrieve]
  25. el-Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Canman, C. E., Jackman, J., Pietenpol, J. A., Burrell, M., Hill, D. E., Wang, Y., et al. (1994) Cancer Res. 54, 1169-1174[Abstract/Free Full Text]
  26. Biggs, J. R., Kudlow, J. E., and Kraft, A. S. (1996) J. Biol. Chem. 271, 901-906[Abstract/Free Full Text]
  27. Zeng, Y. X., Somasundaram, K., and el-Deiry, W. S. (1997) Nat. Genet. 15, 78-82[CrossRef][Medline] [Order article via Infotrieve]
  28. Chin, Y. E., Kitagawa, M., Su, W. C., You, Z. H., Iwamoto, Y., and Fu, X. Y. (1996) Science 272, 719-722[Abstract]
  29. Chinery, R., Brockman, J. A., Peeler, M. O., Shyr, Y., Beauchamp, R. D., and Coffey, R. J. (1997) Nat. Med. 3, 1233-1241[CrossRef][Medline] [Order article via Infotrieve]
  30. O'Reilly, M. A., Staversky, R. J., Watkins, R. H., Reed, C. K., de Mesy Jensen, K. L., Finkelstein, J. N., and Keng, P. C. (2001) Am. J. Respir. Cell Mol. Biol. 24, 703-710[Abstract/Free Full Text]
  31. Monick, M. M., Powers, L., Butler, N., Yarovinsky, T., and Hunninghake, G. W. (2002) Am. J. Physiol. 283, L390-L402
  32. Petrache, I., Choi, M. E., Otterbein, L. E., Chin, B. Y., Mantell, L. L., Horowitz, S., and Choi, A. M. (1999) Am. J. Physiol. 277, L589-L595[Medline] [Order article via Infotrieve]
  33. Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., and Swindell, E. (1995) Mol. Biol. Cell 6, 387-400[Abstract]
  34. Deng, C., Zhang, P., Harper, J. W., Elledge, S. J., and Leder, P. (1995) Cell 82, 675-684[CrossRef][Medline] [Order article via Infotrieve]
  35. Davis, W. B., Rennard, S. I., Bitterman, P. B., and Crystal, R. G. (1983) N. Engl. J. Med. 309, 878-883[Abstract]
  36. Nerurkar, L. S., Zeligs, B. J., and Bellanti, J. A. (1988) Ann. Allergy 61, 344-347[Medline] [Order article via Infotrieve]
  37. Weston, C. R., Balmanno, K., Chalmers, C., Hadfield, K., Molton, S. A., Ley, R., Wagner, E. F., and Cook, S. J. (2003) Oncogene 22, 1281-1293[CrossRef][Medline] [Order article via Infotrieve]
  38. Kinoshita, T., Shirouzu, M., Kamiya, A., Hashimoto, K., Yokoyama, S., and Miyajima, A. (1997) Oncogene 15, 619-627[CrossRef][Medline] [Order article via Infotrieve]
  39. Xue, L., Murray, J. H., and Tolkovsky, A. M. (2000) J. Biol. Chem. 275, 8817-8824[Abstract/Free Full Text]
  40. LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., and Harlow, E. (1997) Genes Dev. 11, 847-862[Abstract/Free Full Text]
  41. Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., and Sherr, C. J. (1999) EMBO J. 18, 1571-1583[CrossRef][Medline] [Order article via Infotrieve]
  42. Kelman, Z., and O'Donnell, M. (1995) Nucleic Acids Res. 23, 3613-3620[Abstract/Free Full Text]
  43. Waga, S., and Stillman, B. (1998) Annu. Rev. Biochem. 67, 721-751[CrossRef][Medline] [Order article via Infotrieve]
  44. Polyak, K., Waldman, T., He, T. C., Kinzler, K. W., and Vogelstein, B. (1996) Genes Dev. 10, 1945-1952[Abstract/Free Full Text]
  45. Gorospe, M., Cirielli, C., Wang, X., Seth, P., Capogrossi, M. C., and Holbrook, N. J. (1997) Oncogene 14, 929-935[CrossRef][Medline] [Order article via Infotrieve]
  46. Asada, M., Yamada, T., Ichijo, H., Delia, D., Miyazono, K., Fukumuro, K., and Mizutani, S. (1999) EMBO J. 18, 1223-1234[CrossRef][Medline] [Order article via Infotrieve]
  47. Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., and Jacks, T. (1995) Genes Dev. 9, 935-944[Abstract/Free Full Text]
  48. Sewing, A., Wiseman, B., Lloyd, A. C., and Land, H. (1997) Mol. Cell. Biol. 17, 5588-5597[Abstract]
  49. Woods, D., Parry, D., Cherwinski, H., Bosch, E., Lees, E., and McMahon, M. (1997) Mol. Cell. Biol. 17, 5598-5611[Abstract]
  50. Pumiglia, K. M., and Decker, S. J. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 448-452[Abstract/Free Full Text]
  51. Bartek, J., Bartkova, J., and Lukas, J. (1997) Exp. Cell Res. 237, 1-6[CrossRef][Medline] [Order article via Infotrieve]
  52. Sherr, C. J. (1996) Science 274, 1672-1677[Abstract/Free Full Text]
  53. Bai, F., Matsui, T., Ohtani-Fujita, N., Matsukawa, Y., Ding, Y., and Sakai, T. (1998) FEBS Lett. 437, 61-64[CrossRef][Medline] [Order article via Infotrieve]
  54. Cicchillitti, L., Fasanaro, P., Biglioli, P., Capogrossi, M. C., and Martelli, F. (2003) J. Biol. Chem. 278, 19509-19517[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
IOVSHome page
M. Shibuya, H. Okamoto, T. Nozawa, J. Utsumi, V. N. Reddy, H. Echizen, Y. Tanaka, and T. Iwata
Proteomic and Transcriptomic Analyses of Retinal Pigment Epithelial Cells Exposed to REF-1/TFPI-2
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 516 - 521.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Nyunoya, M. M. Monick, L. S. Powers, T. O. Yarovinsky, and G. W. Hunninghake
Macrophages Survive Hyperoxia via Prolonged ERK Activation Due to Phosphatase Down-regulation
J. Biol. Chem., July 15, 2005; 280(28): 26295 - 26302.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. V. Truong, M. M. Monick, T. O. Yarovinsky, L. S. Powers, T. Nyunoya, and G. W. Hunninghake
Extracellular Signal-Regulated Kinase Activation Delays Hyperoxia-Induced Epithelial Cell Death in Conditions of Akt Downregulation
Am. J. Respir. Cell Mol. Biol., December 1, 2004; 31(6): 611 - 618.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ahmad, A. Ahmad, M. Ghosh, C. C. Leslie, and C. W. White
Extracellular ATP-mediated Signaling for Survival in Hyperoxia-induced Oxidative Stress
J. Biol. Chem., April 16, 2004; 279(16): 16317 - 16325.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. M. Monick, T. O. Yarovinsky, L. S. Powers, N. S. Butler, A. B. Carter, G. Gudmundsson, and G. W. Hunninghake
Respiratory Syncytial Virus Up-regulates TLR4 and Sensitizes Airway Epithelial Cells to Endotoxin
J. Biol. Chem., December 26, 2003; 278(52): 53035 - 53044.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/38/36099    most recent
M304370200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nyunoya, T.
Right arrow Articles by Hunninghake, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nyunoya, T.
Right arrow Articles by Hunninghake, G. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE